drugset / Trial / NCT07353450

A Study of Cizutamig for Patients With Ulcerative Colitis

NCT07353450 ↗

Phase 0 Not yet recruiting 15 enrolled Ruijin Hospital
NaSingle-groupOpen-labelTreatment

Summary

A Study of Cizutamig for Patients with Ulcerative Colitis

Timeline

Start
2026-01
Primary completion
2027-12
Completion
2027-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Cizutamig Protein / enzyme biologic — Intravenous

Indications